Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (91-100 of 299) with videos related to

Pageof 30
Sort By:
Clinical Immunology (Orlando, Fla.)|June 15, 2014
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokineticsCarla Casulo, Julie M Vose, William Y Ho, et al.
Leukemia & Lymphoma|September 18, 2012
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation studyJulie M Vose, Jonathan W Friedberg, Edmund K Waller, et al.
Blood Reviews|October 4, 2015
Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Javeed Iqbal, Hina Naushad, Chengfeng Bi, et al.
Future Oncology (London, England)|April 16, 2016
Secondary acute myeloid leukemia in survivors of Hodgkin lymphomaVijaya R Bhatt, Smith Giri, Vivek Verma, et al.
Oncology (Williston Park, N.Y.)|January 13, 2009
Adult Burkitt lymphoma: advances in diagnosis and treatmentIbrahim T Aldoss, Dennis D Weisenburger, Kai Fu, et al.
Cancer|October 19, 2011
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphomaBruce D Cheson, Nancy L Bartlett, Julie M Vose, et al.
Clinical Immunology (Orlando, Fla.)|June 23, 2024
MiR-17∼92 is involved in NF-κB activation via targeting the ubiquitin-editing proteins to mediate RIP1 complex polyubiquitinations in ABC-DLBCLXiaoyan Zhang, Xuan Zhang, Xin Huang, et al.
Environmental Health Insights|March 22, 2013
Atrazine and nitrate in public drinking water supplies and non-hodgkin lymphoma in nebraska, USAMartha G Rhoades, Jane L Meza, Cheryl L Beseler, et al.
Hematological Oncology|June 13, 2023
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphomaLimei Poon, Laurence de Leval, Siok Bian Ng, et al.
Molecular Cancer Therapeutics|June 6, 2008
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphomaGanapati V Hegde, Corey M Munger, Katy Emanuel, et al.
Pageof 30

Showing results (91-100 of 299) with videos related to

Sort By:
Pageof 30
Clinical Immunology (Orlando, Fla.)|June 15, 2014
A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokineticsCarla Casulo, Julie M Vose, William Y Ho, et al.
Leukemia & Lymphoma|September 18, 2012
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation studyJulie M Vose, Jonathan W Friedberg, Edmund K Waller, et al.
Blood Reviews|October 4, 2015
Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Javeed Iqbal, Hina Naushad, Chengfeng Bi, et al.
Future Oncology (London, England)|April 16, 2016
Secondary acute myeloid leukemia in survivors of Hodgkin lymphomaVijaya R Bhatt, Smith Giri, Vivek Verma, et al.
Oncology (Williston Park, N.Y.)|January 13, 2009
Adult Burkitt lymphoma: advances in diagnosis and treatmentIbrahim T Aldoss, Dennis D Weisenburger, Kai Fu, et al.
Cancer|October 19, 2011
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphomaBruce D Cheson, Nancy L Bartlett, Julie M Vose, et al.
Clinical Immunology (Orlando, Fla.)|June 23, 2024
MiR-17∼92 is involved in NF-κB activation via targeting the ubiquitin-editing proteins to mediate RIP1 complex polyubiquitinations in ABC-DLBCLXiaoyan Zhang, Xuan Zhang, Xin Huang, et al.
Environmental Health Insights|March 22, 2013
Atrazine and nitrate in public drinking water supplies and non-hodgkin lymphoma in nebraska, USAMartha G Rhoades, Jane L Meza, Cheryl L Beseler, et al.
Hematological Oncology|June 13, 2023
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphomaLimei Poon, Laurence de Leval, Siok Bian Ng, et al.
Molecular Cancer Therapeutics|June 6, 2008
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphomaGanapati V Hegde, Corey M Munger, Katy Emanuel, et al.
Pageof 30